Oncogenic signaling pathways found in liver cancers, such as growth factor receptor signaling, Wnt, and Notch, have been reported to promote YAP/TAZ activity to synergize cell proliferation and survival following anticancer treatment (Tschaharganeh et al. 2013; Kim et al. 2017; Moon et al. 2022). Here, YAP1 is linked to liver cancer.